BlackRock Investment Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-55
| Closed | -$6K | – | 4114 |
|
|
2016
Q1 | $6K | Buy |
55
+1
| +2% | +$109 | ﹤0.01% | 3756 |
|
|
2015
Q4 | $10K | Buy |
54
+5
| +10% | +$926 | ﹤0.01% | 3675 |
|
|
2015
Q3 | $8K | Hold |
49
| – | – | ﹤0.01% | 3780 |
|
|
2015
Q2 | $31K | Sell |
49
-734
| -94% | -$464K | ﹤0.01% | 3333 |
|
|
2015
Q1 | $403K | Buy |
783
+92
| +13% | +$47.4K | ﹤0.01% | 3030 |
|
|
2014
Q4 | $370K | Buy |
691
+2
| +0.3% | +$1.07K | ﹤0.01% | 3120 |
|
|
2014
Q3 | $1.03M | Buy |
689
+10
| +1% | +$15K | ﹤0.01% | 2493 |
|
|
2014
Q2 | $930K | Buy |
679
+187
| +38% | +$256K | ﹤0.01% | 2644 |
|
|
2014
Q1 | $684K | Buy |
492
+65
| +15% | +$90.4K | ﹤0.01% | 2759 |
|
|
2013
Q4 | $425K | Sell |
427
-13
| -3% | -$12.9K | ﹤0.01% | 3006 |
|
|
2013
Q3 | $458K | Buy |
440
+34
| +8% | +$35.4K | ﹤0.01% | 2956 |
|
|
2013
Q2 | $442K | Buy |
+406
| New | +$442K | ﹤0.01% | 2915 |
|